By Roz Sweeney, Ph.D., Nerac Analyst,
Originally Published: June 15, 2015
Social media is becoming increasingly important for promoting the messages of medical technology companies. Sites like Twitter, LinkedIn, Facebook, and Google Plus are important sources of product information and updates for patients, doctors, payers, and investors. The FDA is also using these social media sites to communicate with the public about product recalls, approvals and regulatory changes.
- 66By Rosemarie Szostak, Ph.D., Nerac Analyst Originally published June 24, 2019 Social media mining of consumer trends is not just for your marketing department anymore. It should be part of your overall corporate R&D/innovation toolkit. The world is awash in data ranging from e-commerce, in-store data, and the supply chain. Today, big data has gotten…
- 39By Roz Sweeney, Ph.D., Nerac Analyst Originally Published: November 17th, 2014 Introduction The FDA recently issued updated draft guidance for proposed regulatory changes affecting laboratory developed tests (LDTs). Laboratory developed tests (or LDTs) are traditionally IVDs developed and used by CLIA labs for treating or testing patients within that lab’s associated healthcare facility. They have…
- 36New analyst brings experience in medical devices, neuroscience and biology. Read the full release here.